EU: Mylan rejects Teva’s $40.1 billion buyout offer
Mylan rejected Teva Pharmaceuticals’ $40.1 billion buyout offer, saying the cash-and-stock proposal undervalues the company. Mylan said that it won’t
Mylan rejected Teva Pharmaceuticals’ $40.1 billion buyout offer, saying the cash-and-stock proposal undervalues the company. Mylan said that it won’t
Telecoms regulator Ofcom said that from 1 July, the cost of entering competitions or casting votes on TV and radio
Charges against Russian energy company Gazprom stem from Lithuania’s government, not energy companies, a Russian envoy told a European news
EBay Inc Chief Executive John Donahoe has supported arguments made by Google Inc in its defense in an antitrust case,
US based Applied Materials on Monday scrapped its $10 billion planned takeover of chip-making gear rival Tokyo Electron after the
Posted by Social Science Research Network When Competition Fails to Optimise Quality: A Look at Search Engines Maurice E. Stucke
Generic drug company Mylan increased its offer for over-the-counter giant Perrigo Friday, days after Israel’s Teva attempted to head off
In a recently released report, Reuters has revealed that the European Union (EU)’s last-week-announced decision with regard to an antitrust
Chinese online game developer Perfect World on Sunday said it has entered into an agreement and plan of merger with
Friday morning HSBC announced that it is going to look – again – at whether it would be better served
© Competition Policy International 2024